First case report in Latin America: Oral treatment of multidrug-resistant tuberculosis with delamanid and bedaquiline in combination with linezolid, moxifloxacin and clofazimine following a DRESS syndrome in a peruvian patient

Thumbnail
Date
2021
Author(s)
Pecho-Silva, S.
Navarro-Solsol, A.C.
Metadata
Show full item record
Abstract
The World Health Organization recommends the use of oral medications for the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB).Citation However, few countries have adopted these recommendations, either due to lack of medication or because of outdated local recommendations, as in the case of Peru.Citation The combination of some medications for the treatment of MDR TB such as delamanid (Dlm) with bedaquiline (Bdq) has been associated with a potential risk of cardiovascular symptoms such as prolongation of the QT interval corrected by Fridericia interval (QTcF)...
URI
https://hdl.handle.net/20.500.12805/4765
DOI
https://doi.org/10.1016/j.pulmoe.2020.03.005
Collections
Subject
https://purl.org/coar/access_right/c_abf2
Except where otherwise noted, this item's license is described as https://purl.org/coar/access_right/c_abf2